Concourse Financial Group Securities, Inc. Molecular Partners Ag Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q1 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding MOLN
# of Institutions
7Shares Held
3.58MCall Options Held
0Put Options Held
0-
Suvretta Capital Management, LLC New York, NY2.22MShares$9.04 Million0.38% of portfolio
-
Bvf Inc San Francisco, CA1.35MShares$5.51 Million0.23% of portfolio
-
Ubs Group Ag6.35KShares$25,8480.0% of portfolio
-
Morgan Stanley New York, NY367Shares$1,4930.0% of portfolio
-
Rhumbline Advisers Boston, MA269Shares$1,0940.0% of portfolio
About MOLECULAR PARTNERS AG
- Ticker MOLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,514,000
- Market Cap $132M
- Description
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...